- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/60 - NaphthoxazolesHydrogenated naphthoxazoles
Patent holdings for IPC class C07D 263/60
Total number of patents in this class: 48
10-year publication summary
|
2
|
5
|
1
|
3
|
1
|
2
|
3
|
3
|
4
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17635 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
4 |
| Universitat de Valencia | 227 |
3 |
| Bayer Cropscience AG | 2040 |
2 |
| FUJIFILM Corporation | 29437 |
2 |
| Biotix, Inc. | 181 |
2 |
| The Brigham and Women's Hospital, Inc. | 2195 |
2 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
2 |
| Huen Co.,Ltd. | 5 |
2 |
| Samsung Display Co., Ltd. | 34907 |
1 |
| Boehringer Ingelheim International GmbH | 4642 |
1 |
| Chevron Oronite Company LLC | 570 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10931 |
1 |
| JSR Corporation | 2527 |
1 |
| Adeka Corporation | 1365 |
1 |
| China Pharmaceutical University | 301 |
1 |
| Duk San Neolux Co., Ltd. | 654 |
1 |
| Enanta Pharmaceuticals, Inc. | 429 |
1 |
| Irm LLC | 157 |
1 |
| Presidio Pharmaceuticals, Inc. | 17 |
1 |
| Other owners | 14 |